INDP
Price
$2.07
Change
-$0.24 (-10.39%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
4.05M
Intraday BUY SELL Signals
SLNO
Price
$47.00
Change
-$1.54 (-3.17%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.61B
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INDP vs SLNO

Header iconINDP vs SLNO Comparison
Open Charts INDP vs SLNOBanner chart's image
Indaptus Therapeutics
Price$2.07
Change-$0.24 (-10.39%)
Volume$1.47K
Capitalization4.05M
Soleno Therapeutics
Price$47.00
Change-$1.54 (-3.17%)
Volume$148.17K
Capitalization2.61B
INDP vs SLNO Comparison Chart in %
INDP
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
INDP vs. SLNO commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDP is a Hold and SLNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (INDP: $2.31 vs. SLNO: $48.54)
Brand notoriety: INDP and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INDP: 4% vs. SLNO: 61%
Market capitalization -- INDP: $3.68M vs. SLNO: $2.52B
INDP [@Biotechnology] is valued at $3.68M. SLNO’s [@Biotechnology] market capitalization is $2.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDP’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • INDP’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both INDP and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDP’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • INDP’s TA Score: 4 bullish, 4 bearish.
  • SLNO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, INDP is a better buy in the short-term than SLNO.

Price Growth

INDP (@Biotechnology) experienced а -15.07% price change this week, while SLNO (@Biotechnology) price change was -0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

SLNO is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($2.61B) has a higher market cap than INDP($4.05M). SLNO YTD gains are higher at: 7.987 vs. INDP (-90.203). INDP has higher annual earnings (EBITDA): -16.34M vs. SLNO (-176.1M). SLNO has more cash in the bank: 287M vs. INDP (6.16M). INDP has less debt than SLNO: INDP (6.54M) vs SLNO (52.8M). SLNO has higher revenues than INDP: SLNO (32.7M) vs INDP (0).
INDPSLNOINDP / SLNO
Capitalization4.05M2.61B0%
EBITDA-16.34M-176.1M9%
Gain YTD-90.2037.987-1,129%
P/E RatioN/AN/A-
Revenue032.7M-
Total Cash6.16M287M2%
Total Debt6.54M52.8M12%
FUNDAMENTALS RATINGS
INDP vs SLNO: Fundamental Ratings
INDP
SLNO
OUTLOOK RATING
1..100
6259
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
40
Fair valued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9788
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INDP's Valuation (12) in the null industry is in the same range as SLNO (40) in the Medical Specialties industry. This means that INDP’s stock grew similarly to SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (70) in the Medical Specialties industry is in the same range as INDP (100) in the null industry. This means that SLNO’s stock grew similarly to INDP’s over the last 12 months.

SLNO's SMR Rating (97) in the Medical Specialties industry is in the same range as INDP (100) in the null industry. This means that SLNO’s stock grew similarly to INDP’s over the last 12 months.

SLNO's Price Growth Rating (88) in the Medical Specialties industry is in the same range as INDP (97) in the null industry. This means that SLNO’s stock grew similarly to INDP’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as INDP (100) in the null industry. This means that SLNO’s stock grew similarly to INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDPSLNO
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 22 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
INDP
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMJAX10.84N/A
N/A
PIMCO RAE US Small A
HGXYX16.30N/A
N/A
Hartford Global Impact Y
PJDAX19.11N/A
N/A
PGIM Jennison Rising Dividend A
RGLDX27.39-0.27
-0.98%
American Funds Global Insight R-3
EGINX36.60-0.41
-1.11%
Invesco International Value Investor

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
+1.76%
UNCY - INDP
53%
Loosely correlated
+2.60%
ALT - INDP
45%
Loosely correlated
+10.98%
RVPH - INDP
30%
Poorly correlated
+9.77%
SLNO - INDP
30%
Poorly correlated
+2.73%
VKTX - INDP
30%
Poorly correlated
-1.20%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+2.73%
BRNS - SLNO
56%
Loosely correlated
-7.71%
BHVN - SLNO
41%
Loosely correlated
+14.27%
GRCE - SLNO
38%
Loosely correlated
+5.33%
SYRE - SLNO
35%
Loosely correlated
-1.07%
KROS - SLNO
35%
Loosely correlated
+0.98%
More